EGFR and non-small cell lung carcinoma: Given that little is known of the relation between such EGFR alterations and the response to treatment with anti-EGFR mAbs, we investigated the antitumor effect of combined treatment with the anti-EGFR mAb nimotuzumab and radiation in NSCLC cell lines of differing EGFR status.